Ignite Creation Date:
2025-12-25 @ 12:57 AM
Ignite Modification Date:
2025-12-25 @ 11:11 PM
Study NCT ID:
NCT04553393
Status:
UNKNOWN
Last Update Posted:
2020-12-04
First Post:
2020-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-09-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-10
First Submit QC Date:
None
Study First Post Date:
2020-09-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-03
Last Update Post Date:
2020-12-04
Last Update Post Date Type:
ACTUAL